<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochem Biophys Res Commun</journal-id>
      <journal-title-group>
        <journal-title>Biochemical and Biophysical Research Communications</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-291X</issn>
      <issn pub-type="epub">1090-2104</issn>
      <publisher>
        <publisher-name>Academic Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2832732</article-id>
      <article-id pub-id-type="pmid">18586007</article-id>
      <article-id pub-id-type="publisher-id">YBBRC21276</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbrc.2008.06.068</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Epigallocatechin activates haem oxygenase-1 expression via protein kinase Cδ and Nrf2</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ogborne</surname>
            <given-names>Richard M.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rushworth</surname>
            <given-names>Stuart A.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>O’Connell</surname>
            <given-names>Maria A.</given-names>
          </name>
          <email>m.oconnell@uea.ac.uk</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>MRC Human Nutrition Research, Fulbourn Road, Cambridge CB1 9NL, UK</aff>
      <aff id="aff2"><label>b</label>School of Chemical Sciences and Pharmacy, University of East Anglia, Norwich NR4 7TJ, UK</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Address: School of Chemical Sciences and Pharmacy, University of East Anglia, Earlham Road, Norwich NR4 7TJ, UK. Fax: +44 (0)1603 592003. <email>m.oconnell@uea.ac.uk</email></corresp>
        <fn id="fn1">
          <label>1</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>05</day>
        <month>9</month>
        <year>2008</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>05</day>
        <month>9</month>
        <year>2008</year>
      </pub-date>
      <volume>373</volume>
      <issue>4</issue>
      <fpage>584</fpage>
      <lpage>588</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>6</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2008 Elsevier Inc.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The Nrf2/anti-oxidant response element (ARE) pathway plays an important role in regulating cellular anti-oxidants, including haem oxygenase-1 (HO-1). Various kinases have been implicated in the pathways leading to Nrf2 activation. Here, we investigated the effect of epigallocatechin (EGC) on ARE-mediated gene expression in human monocytic cells. EGC time and dose dependently increased HO-1 mRNA and protein expression but had minimal effect on expression of other ARE-regulated genes, including NAD(P)H:quinone oxidoreductase 1, glutathione cysteine ligase and ferritin. siRNA knock down of Nrf2 significantly inhibited EGC-induced HO-1 expression. Furthermore, inhibition of PKC by Ro-31-8220 dose dependently decreased EGC-induced HO-1 mRNA expression, whereas MAP kinase and phosphatidylinositol-3-kinase pathway inhibitors had no significant effect. EGC stimulated phosphorylation of PKCαβ and δ in THP-1 cells. PKCδ inhibition significantly decreased EGC-induced HO-1 mRNA expression, whereas PKCα- and β-specific inhibitors had no significant effect. These results demonstrate for the first time that EGC-induced HO-1 expression occurs via PKCδ and Nrf2.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Epigallocatechin</kwd>
        <kwd>Haem oxygenase-1</kwd>
        <kwd>Monocytic cells</kwd>
        <kwd>Nrf2</kwd>
        <kwd>Protein kinase C</kwd>
        <kwd>Green tea polyphenols</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Catechins, a family of plant polyphenols, exert anti-oxidant, anti-inflammatory and anti-proliferative effects in vitro and in vivo <xref rid="bib1 bib2" ref-type="bibr">[1,2]</xref>. This may be in part due to their activation of Phase II enzymes and cellular anti-oxidants, including NAD(P)H:quinone oxidoreductase 1 (NQO1), catalase and enzymes involved in glutathione synthesis <xref rid="bib3 bib4 bib5" ref-type="bibr">[3–5]</xref>. These and other cytoprotective molecules, including haem oxygenase-1 (HO-1, the rate-limiting enzyme in haem catabolism) and the iron-binding protein ferritin, contain anti-oxidant response elements (ARE) in the regulatory regions of their genes. The transcription factor NF-E2-related factor 2 (Nrf2) binds to this regulatory element and plays a key role in ARE-driven gene transcription <xref rid="bib6" ref-type="bibr">[6]</xref>. Nrf2 knockout mice are deficient in cellular anti-oxidants and are susceptible to inflammation <xref rid="bib7 bib8" ref-type="bibr">[7,8]</xref>, demonstrating the importance of this pathway in cellular defence. Several kinase pathways have been implicated in activation of Nrf2 including the ERK and p38 MAP kinase pathways, phosphatidyl inositol 3 kinase and protein kinase C (PKC) <xref rid="bib9 bib10 bib11 bib12 bib13 bib14" ref-type="bibr">[9–14]</xref>.</p>
    <p>Green tea is a rich source of catechins, comprising over 30% of its dry weight <xref rid="bib15" ref-type="bibr">[15]</xref>. Green tea extract activates ARE-mediated reporter activity <xref rid="bib16" ref-type="bibr">[16]</xref>. EGCG is the most abundant catechin in green tea and studies to date have focused on this compound. EGCG stimulates expression of many Nrf2-dependent genes in liver and intestine in mice and activates HO-1 expression in B lymphoblasts, epithelial and endothelial cells <xref rid="bib13 bib14 bib17 bib18" ref-type="bibr">[13,14,17,18]</xref>. Epigallocatechin (EGC) is also a major catechin in green tea <xref rid="bib19" ref-type="bibr">[19]</xref>. Although EGCG and EGC are structurally similar except for the addition of a 3-gallate group in EGCG, their biological effects differ extensively <xref rid="bib3 bib20 bib21 bib22 bib23 bib24 bib25 bib26" ref-type="bibr">[3,20–26]</xref>. EGC is also more bioavailable than EGCG and other catechins and oral administration of EGC, but not EGCG, results in a significant increase in plasma anti-oxidant activity <xref rid="bib27" ref-type="bibr">[27]</xref>.</p>
    <p>Monocytes play an essential role in the host response to oxidative stress and inflammation. In the present study, the effects of EGC on ARE-mediated gene expression were examined in THP-1 cells, a human monocytic cell line that we have previously used to examine ARE-mediated gene expression <xref rid="bib9 bib10 bib11" ref-type="bibr">[9–11]</xref>. In addition, the role of Nrf2 and the various potential kinase pathways leading to Nrf2 activation were investigated.</p>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <p><italic>Materials.</italic> LY333531 was purchased from Alexis Biotechnologies (Nottingham, UK). SB203580, Ro-31-8220, rottlerin, LY294002, Go6976 and PD98059 were obtained from Calbiochem (Nottingham, UK). (−)Epigallocatechin and all other chemicals were purchased from Sigma (Poole, UK).</p>
      <p><italic>Cell culture.</italic> THP-1, a human monocytic leukaemia cell line <xref rid="bib28" ref-type="bibr">[28]</xref>, was purchased from ECACC (Porton Down, UK) and cultured in RPMI 1640 medium supplemented with 10% foetal calf serum, 2 mM <sc>l</sc>-glutamine (Biowhittaker, Wokingham, UK) and 2-mercaptoethanol. Cells were maintained in a humidified atmosphere at 37 °C and 5% CO<sub>2</sub>.</p>
      <p><italic>Western immunoblotting.</italic> Cells (1 × 10<sup>6</sup>) were unstimulated or stimulated with EGC and whole cell lysates prepared, proteins separated and immunoblotting carried out as previously described <xref rid="bib11" ref-type="bibr">[11]</xref>. Antibodies were purchased from the following: mouse anti-human HO-1 antibody (Stressgen Biotechnologies Corporation, Victoria, Canada); rabbit anti-human phosphorylated PKCαβ and PKCδ antibodies (Cell Signalling Technology, Beverley, USA); mouse anti-human endogenous PKCδ antibody (BD Biosciences, CA, USA); goat anti-mouse and goat anti-rabbit secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, USA); mouse anti-human β-actin antibody (Sigma).</p>
      <p><italic>Real-time PCR.</italic> Cells (5 × 10<sup>5</sup>) were unstimulated or stimulated with EGC for various times at 37 °C. In some experiments, cells were pre-treated with kinase inhibitors for 30 min prior to EGC stimulation. RNA extraction, reverse transcription, and real-time PCR were carried out as previously described <xref rid="bib10" ref-type="bibr">[10]</xref>. Relative quantitative mRNA expression of HO-1, NQO1, GCLM or ferritin was normalized to 18s ribosomal unit mRNA expression.</p>
      <p><italic>Nrf2 siRNA transfection.</italic> Nrf2 siRNA sense sequences 5′-GAGUAUGAGCUGGAAAAACtt-3′ (siNrf2 A) <xref rid="bib29" ref-type="bibr">[29]</xref>, 5′-CCUUAUAUCUCGAAGUUUUtt-3′ (siNrf2 B), their complementary antisense sequences and negative controls were obtained from Ambion as purified annealed duplexes. THP-1 cells (5 × 10<sup>4</sup>/well) were transfected in serum-free media with control siRNA or Nrf2-targeted siRNA (30 nM final concentration), using Oligofectamine transfection reagent according to the manufacturer’s instructions (Invitrogen). Transfected cells were incubated for 48 h, with addition of 10% FCS at 4 h. Following this, cells were stimulated with EGC for 4 h before RNA extraction and real-time PCR analysis.</p>
      <p><italic>PKCδ antisense oligodeoxyribonucleotide (ODN) transfection.</italic> THP-1 cells (5 × 10<sup>4</sup>) were transfected in serum-free media with sense or antisense ODN to PKCδ, using Oligofectamine transfection reagent (Invitrogen), as previously described <xref rid="bib10" ref-type="bibr">[10]</xref>. Following transfection, cells were unstimulated or stimulated with EGC for 4 h, total RNA extracted and real-time PCR performed.</p>
      <p><italic>Statistical analyses.</italic> Where indicated, statistical analyses were performed using paired Student’s <italic>t</italic> test. Results are means ± SD of three independent experiments. Results with <italic>p</italic> &lt; 0.05 were considered statistically significant.</p>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>EGC increases HO-1 expression in THP-1 cells</title>
        <p>EGC increased HO-1 mRNA expression in THP-1 cells, peaking at 4 h (<italic>p</italic> &lt; 0.01), remaining elevated at 8 h (<italic>p</italic> &lt; 0.01) and returning to baseline by 24 h (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A). This correlated with an elevation in HO-1 protein expression by 4 h, which further increased by 8 h and decreased, but was still evident, at 24 h (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B). EGC also time and dose dependently increased GCLM mRNA expression in THP-1 cells with maximal induction at 4 h. However, the induction was much weaker than that seen with HO-1 (GCLM at 4 h, 50 μM EGC, 2.5 ± 0.5, <italic>p</italic> &lt; 0.01; 100 μM EGC, 3.0 ± 1.30, <italic>p</italic> &lt; 0.01, mean fold increase above control ± SD, <italic>n</italic> = 7). EGC (12.5–100 μM) had no significant effect on either NQO1 or ferritin gene expression up to 24 h (data not shown). To ensure that EGC-induced HO-1 expression was not the result of toxicity, THP-1 cells pre-incubated with EGC for 24 h were analysed by MTT assay. At concentrations up to 125 μM THP-1 cells remained 96% (±2.3) viable compared to control cells, suggesting that the EGC concentrations used in this study did not exert cytotoxic effects.</p>
      </sec>
      <sec>
        <title>Role of Nrf2 in EGC-induced HO-1 expression</title>
        <p>Nrf2 plays a key role in HO-1 regulation. The role of Nrf2 in EGC-induced HO-1 expression was confirmed by use of siRNA. THP-1 cells were transiently transfected with control or two different Nrf2 siRNAs and Nrf2 mRNA expression measured by real-time PCR. <xref rid="fig2" ref-type="fig">Fig. 2</xref>A demonstrates that both Nrf2 siRNAs significantly inhibited Nrf2 mRNA expression to a similar extent when compared with the negative control (black bars, <italic>p</italic> = 0.004, <italic>p</italic> = 0.0002, respectively). These siRNAs also inhibited Nrf2 protein expression (data not shown). In addition, they significantly inhibited EGC-induced HO-1 mRNA expression (grey bars, A, 60.7 ± 8.9, <italic>p</italic> = 0.01; B, 66.1 ± 2.6, <italic>p</italic> = 0.0007; mean ± SD% inhibition, <italic>n</italic> = 3), confirming that Nrf2 plays a key role in this pathway in THP-1 cells.</p>
      </sec>
      <sec>
        <title>Investigation of kinase pathways regulating EGC-induced HO-1 expression</title>
        <p>THP-1 cells were pre-treated with LY294002 (a PI3K inhibitor), SB203580 (a p38 MAPK inhibitor), PD98059 (an ERK MAPK pathway inhibitor) or Ro-31-8220 (a pan-PKC inhibitor) prior to stimulation with EGC. LY294002, SB203580 and PD98059 had no significant effect on EGC-induced HO-1 mRNA expression. However, pre-treatment with Ro-31-8220 abolished EGC-induced HO-1 mRNA expression (<italic>p</italic> &lt; 0.05) (<xref rid="fig3" ref-type="fig">Fig. 3</xref>A), suggesting that this response is regulated by PKC. The effect of Ro-31-8220 upon EGC-induced HO-1 mRNA expression was concentration-dependent, confirming the specificity of this effect (<xref rid="fig3" ref-type="fig">Fig. 3</xref>B). Ro-31-8220 (5 μM) also completely abolished EGC-induced GCLM mRNA expression in these cells (data not shown). Furthermore, EGC induced phosphorylation of PKC within 5 min, peaked at 20 min (<xref rid="fig3" ref-type="fig">Fig. 3</xref>C) and remained phosphorylated at 4 and 8 h (data not shown). These results suggest that PKC plays a key role in EGC-induced HO-1 (and GCLM) expression in THP-1 cells.</p>
      </sec>
      <sec>
        <title>EGC-induced HO-1 expression is regulated by PKCδ</title>
        <p>The PKC family of proteins comprises at least 10 serine/threonine kinases <xref rid="bib30" ref-type="bibr">[30]</xref>. We have shown that LPS and curcumin-induced HO-1 expression in THP-1 cells are mediated via a classical PKC isoform and PKCδ, respectively <xref rid="bib10 bib11" ref-type="bibr">[10,11]</xref>. The potential role of these PKC isoforms in regulating EGC-induced HO-1 expression in THP-1 cells was examined. EGC induced phosphorylation of classical PKCs(αβ) and PKCδ by 5 min, which was sustained at 30 min (<xref rid="fig4" ref-type="fig">Fig. 4</xref>A). This was not the result of a change in expression of unphosphorylated PKC isoforms. Cells were also pre-treated with LY333531 (a PKC β<sub>1</sub>/β<sub>2</sub> inhibitor), Go6976 (a PKCα/β<sub>1</sub> inhibitor) or rottlerin (which inhibits PKCδ and θ at the concentrations used) prior to stimulation with EGC and real-time PCR performed. LY333531 and Go6976 exerted no significant effect on EGC-induced HO-1 mRNA expression, suggesting that classical PKC isoforms are not important for this pathway. However, 15 μM rottlerin significantly inhibited EGC-induced HO-1 mRNA expression (<italic>p</italic> &lt; 0.05) (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B), suggesting that, similarly to curcumin, PKCδ may be important in HO-1 induction by EGC. Rottlerin, but not Go6976 or LY333531, also inhibited EGC-induced GCLM mRNA expression in THP-1 cells by 61% (data not shown). As rottlerin may also inhibit PKCθ and other kinase pathways, PKCδ antisense ODN were employed to confirm specificity. PKCδ antisense ODN inhibited PKCδ protein expression in THP-1 cells <xref rid="bib10" ref-type="bibr">[10]</xref>. Transfection of PKCδ sense ODN did not affect EGC-induced HO-1 mRNA expression (<xref rid="fig4" ref-type="fig">Fig. 4</xref>C). However, transfection of antisense ODN prior to EGC stimulation resulted in a 78% reduction (<italic>p</italic> &lt; 0.005) in EGC-induced HO-1 mRNA expression, confirming a role for PKCδ in the regulation of EGC-induced HO-1 expression.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Green tea extract activates ARE-dependent gene expression and studies to date have focused on EGCG. In the present study, EGC, a more bioavailable catechin found in green tea, induced HO-1 expression and GCLM expression in human monocytic THP-1 cells. Furthermore, EGC-induced HO-1 expression was regulated by Nrf2 and PKCδ.</p>
      <p>We have previously reported the activation of Nrf2/ARE-mediated gene expression by dietary anti-oxidants in THP-1 cells. Alpha lipoic acid activates Nrf2-mediated HO-1 expression <xref rid="bib9" ref-type="bibr">[9]</xref> and curcumin activates expression of Nrf2-regulated HO-1, NQO1, glutathione cysteine ligase and ferritin <xref rid="bib10" ref-type="bibr">[10]</xref>. However, other dietary anti-oxidants including ascorbic acid, alpha tocopherol, gamma tocopherol and resveratrol do not activate these genes in THP-1 cells (unpublished). In the present study, EGC activated HO-1 and GCLM, but not NQO1 or ferritin expression in THP-1 cells. EGCG minimally increases HO-1 mRNA expression in THP-1 cells (unpublished). EGCG activates HO-1 mRNA and protein expression in epithelial and endothelial cells at similar concentrations used in our study <xref rid="bib14 bib18" ref-type="bibr">[14,18]</xref>. However, in contrast to our results, 100 μM EGC had no effect on HO-1 protein expression in endothelial cells, which may be due to differences in cell type. Nrf2 regulates EGCG-induced HO-1 in B lymphoblasts and epithelial cells <xref rid="bib13 bib18" ref-type="bibr">[13,18]</xref>. Here, EGC also activated Nrf2 in THP-1 cells, and Nrf2 silencing significantly suppressed EGC-induced HO-1 expression, suggesting a key role for this transcription factor in this pathway. However, EGC did not activate ARE-driven reporter activity in HepG2 cells transfected with an ARE reporter <xref rid="bib3" ref-type="bibr">[3]</xref>.</p>
      <p>Small differences in catechin structure result in wide-ranging biological effects. The presence of a 3-gallate group in EGCG and epicatechin gallate (ECG) results in pharmacokinetic differences. EGC is more bioavailable than either EGCG or ECG and oral administration of EGC results in a higher plasma anti-oxidant activity than that seen with gallated catechins <xref rid="bib27" ref-type="bibr">[27]</xref>, suggesting that it may be more important in vivo. In addition, cellular effects differ between gallated and non-gallated catechins. EGCG and ECG, but not EGC, bind to oestrogen receptors in MCF7 cells <xref rid="bib21" ref-type="bibr">[21]</xref>. However, in the same study, EGCG, but not EGC or the gallated ECG, activated oestrogen receptor-mediated gene expression. Catechins also exhibit varying cytotoxic effects in different cells <xref rid="bib3 bib22" ref-type="bibr">[3,22]</xref>. In addition, EGCG, but not EGC, (i) binds to the metastasis-associated laminin receptor in tumour cells, (ii) disrupts liposome membrane structure, (iii) inhibits CYP450 isoforms, (iv) inhibits proteasome activity and (v) suppresses Type I collagen and matrix metalloproteinase 1 production <xref rid="bib20 bib23 bib24 bib25 bib26" ref-type="bibr">[20,23–26]</xref>.</p>
      <p>Several kinase pathways may regulate EGC-induced HO-1 and GCLM expression in THP-1 cells. ALA and curcumin induce HO-1 expression through p38 MAPK in THP-1 cells <xref rid="bib9 bib10" ref-type="bibr">[9,10]</xref>. EGCG also activates Nrf2 expression in B lymphoblasts via p38 MAP kinase <xref rid="bib13" ref-type="bibr">[13]</xref>. Here, the p38 MAPK inhibitor SB203580 did not significantly inhibit EGC-induced HO-1 mRNA expression, suggesting this pathway is not involved. EGC activates ERK MAP kinases in Ehrlich ascites tumour cells and HepG2 cells <xref rid="bib3 bib22" ref-type="bibr">[3,22]</xref> and EGCG-induced HO-1 expression in epithelial and endothelial cells is regulated by ERK MAP kinase and PI3K <xref rid="bib14 bib18" ref-type="bibr">[14,18]</xref>. However, we found that inhibitors of these pathways had no effect on EGC-induced HO-1 expression in THP-1 cells.</p>
      <p>The present study implicates a role for PKCδ in Nrf2-regulated EGC-induced HO-1 expression. PKC regulates ARE-mediated gene expression in various cell types <xref rid="bib10 bib11 bib12" ref-type="bibr">[10–12]</xref>. PKC phosphorylates Nrf2 on Ser40, enabling dissociation from its inhibitor Keap 1 <xref rid="bib31" ref-type="bibr">[31]</xref>. EGCG activates PKC in neuronal, astroglioma and phaeochromacytoma cells <xref rid="bib32 bib33 bib34" ref-type="bibr">[32–34]</xref>. However, PKC inhibitors did not affect EGCG-induced HO-1 expression in endothelial cells <xref rid="bib14" ref-type="bibr">[14]</xref>. We have previously shown that a classical PKC regulates LPS-induced HO-1 expression in monocytes <xref rid="bib11" ref-type="bibr">[11]</xref>. However, inhibitors of classical PKC had no significant effect in this study. However, PKCδ inhibitors suppressed EGC-induced HO-1 expression. In addition, Ro-31-8220 and rottlerin, but not Go6976 or LY333531, significantly inhibited EGC-induced GCLM expression, suggesting that PKCδ also regulates EGC-induced GCLM mRNA expression in THP-1 cells. Curcumin-induced HO-1 and GCLM expression are mediated via PKCδδ in human monocytes and THP-1 cells, suggesting a common pathway of activation for these polyphenols. However, p38 also regulates curcumin-induced HO-1 expression in THP-1 cells <xref rid="bib10" ref-type="bibr">[10]</xref>, suggesting some divergence in the two pathways. Based on our studies and other recent reports <xref rid="bib10 bib12 bib35" ref-type="bibr">[10,12,35]</xref>, PKCδ is emerging as an important member of the signalling pathways leading to Nrf2/ARE-mediated gene expression and its exact role warrants further investigation.</p>
      <p>GCLM is the regulatory unit of the rate-limiting enzyme of glutathione synthesis and GCLM induction leads to an increase in glutathione in cells <xref rid="bib36" ref-type="bibr">[36]</xref>. In the present study, EGC weakly increased GCLM mRNA expression in THP-1 cells. In contrast, EGC decreased glutathione concentrations in Ehrlich ascites tumour cells but this correlated with cell viability <xref rid="bib22" ref-type="bibr">[22]</xref>. EGC was not cytotoxic at the concentrations used here, suggesting this may be a reason for the differences between the two studies. Interestingly, although NQO1 and ferritin are also regulated by the ARE and green tea extract activates NQO1 in vitro and in vivo <xref rid="bib3 bib4" ref-type="bibr">[3,4]</xref>, EGC did not activate these genes in THP-1 cells, suggesting that an alternative catechin may be responsible for the effect of green tea extracts on NQO1 expression or that this effect is cell type-specific.</p>
      <p>In conclusion, EGC, in addition to EGCG, contributes to the activation of cellular anti-oxidants by catechins, including HO-1 and this, in turn, may partially be responsible for the beneficial effects of green tea extracts in vitro and in vivo. HO-1 plays a protective role in models of vascular diseases <xref rid="bib37 bib38" ref-type="bibr">[37,38]</xref>, suggesting that activation of HO-1 by EGC warrants further investigation. In addition, PKCδ regulates EGC-induced HO-1 expression, confirming that this kinase is emerging as an important member of the signalling pathways leading to HO-1.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaveri</surname>
              <given-names>N.T.</given-names>
            </name>
          </person-group>
          <article-title>Green tea and its polyphenolic catechins</article-title>
          <source>Life Sci.</source>
          <volume>78</volume>
          <year>2006</year>
          <fpage>2073</fpage>
          <lpage>2080</lpage>
          <pub-id pub-id-type="pmid">16445946</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stangl</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Dreger</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Stangl</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Molecular targets of tea polyphenols in the cardiovascular system</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>73</volume>
          <year>2007</year>
          <fpage>348</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="pmid">17020753</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Owuor</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>A.N.</given-names>
            </name>
          </person-group>
          <article-title>Activation of anti-oxidant-response element (ARE), mitogen-activated protein kinases (MAPK) and caspases by major green tea polyphenol components during cell survival and death</article-title>
          <source>Arch. Pharm. Res.</source>
          <volume>23</volume>
          <year>2000</year>
          <fpage>605</fpage>
          <lpage>612</lpage>
          <pub-id pub-id-type="pmid">11156183</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Katiyar</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Mukhtar</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Enhancement of anti-oxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention</article-title>
          <source>Cancer Res.</source>
          <volume>52</volume>
          <year>1992</year>
          <fpage>4050</fpage>
          <lpage>4052</lpage>
          <pub-id pub-id-type="pmid">1617681</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quine</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Raghu</surname>
              <given-names>P.S.</given-names>
            </name>
          </person-group>
          <article-title>Effects of (−)-epicatechin, a flavonoid on lipid peroxidation and anti-oxidants in streptozotocin-induced diabetic liver, kidney and heart</article-title>
          <source>Pharmacol. Rep.</source>
          <volume>57</volume>
          <year>2005</year>
          <fpage>610</fpage>
          <lpage>615</lpage>
          <pub-id pub-id-type="pmid">16227644</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Kunsch</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Induction of cytoprotective genes through Nrf2/anti-oxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases</article-title>
          <source>Curr. Pharm. Des.</source>
          <volume>10</volume>
          <year>2004</year>
          <fpage>879</fpage>
          <lpage>891</lpage>
          <pub-id pub-id-type="pmid">15032691</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rangasamy</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mitzner</surname>
              <given-names>W.A.</given-names>
            </name>
            <name>
              <surname>Roman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fryer</surname>
              <given-names>A.D.</given-names>
            </name>
          </person-group>
          <article-title>Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice</article-title>
          <source>J. Exp. Med.</source>
          <volume>202</volume>
          <year>2005</year>
          <fpage>47</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">15998787</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thimmulappa</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rangasamy</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kensler</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Biswal</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis</article-title>
          <source>J. Clin. Invest.</source>
          <volume>116</volume>
          <year>2006</year>
          <fpage>984</fpage>
          <lpage>995</lpage>
          <pub-id pub-id-type="pmid">16585964</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ogborne</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Rushworth</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>O’Connell</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Alpha lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid-2-related factor 2 and p38 mitogen-activated protein kinase in human monocytic cells</article-title>
          <source>Arterioscler. Thromb. Vasc. Biol.</source>
          <volume>25</volume>
          <year>2005</year>
          <fpage>2100</fpage>
          <lpage>2105</lpage>
          <pub-id pub-id-type="pmid">16123320</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rushworth</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Ogborne</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Charalambos</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>O’Connell</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Role of protein kinase C delta in curcumin-induced anti-oxidant response element-mediated gene expression in human monocytes</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>341</volume>
          <year>2006</year>
          <fpage>1007</fpage>
          <lpage>1016</lpage>
          <pub-id pub-id-type="pmid">16460683</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rushworth</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Mackman</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ogborne</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>O’Connell</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C</article-title>
          <source>J. Immunol.</source>
          <volume>175</volume>
          <year>2005</year>
          <fpage>4408</fpage>
          <lpage>4415</lpage>
          <pub-id pub-id-type="pmid">16177082</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Acrolein induces heme oxygenase-1 through PKC-delta and PI3K in human bronchial epithelial cells</article-title>
          <source>Am. J. Respir. Cell Mol. Biol.</source>
          <volume>38</volume>
          <year>2008</year>
          <fpage>483</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">18048804</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andreadi</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Howells</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Atherfold</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Manson</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of Nrf2, p38, B-Raf, and nuclear factor-κB, but not phosphatidylinositol 3-kinase, in induction of heme oxygenase-1 by dietary polyphenols</article-title>
          <source>Mol. Pharm.</source>
          <volume>69</volume>
          <year>2006</year>
          <fpage>1033</fpage>
          <lpage>1040</lpage>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Wung</surname>
              <given-names>B.S.</given-names>
            </name>
          </person-group>
          <article-title>Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways</article-title>
          <source>Life Sci.</source>
          <volume>78</volume>
          <year>2006</year>
          <fpage>2889</fpage>
          <lpage>2897</lpage>
          <pub-id pub-id-type="pmid">16378625</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graham</surname>
              <given-names>H.N.</given-names>
            </name>
          </person-group>
          <article-title>Green tea composition, consumption and polyphenol chemistry</article-title>
          <source>Prev. Med.</source>
          <volume>21</volume>
          <year>1992</year>
          <fpage>334</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="pmid">1614995</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jiao</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Duh</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Gudehithlu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>A.N.</given-names>
            </name>
          </person-group>
          <article-title>Activation of mitogen-activated protein kinases by green tea polyphenols: potential signalling pathways in the regulation of anti-oxidant response element-mediated phase II enzyme gene expression</article-title>
          <source>Carcinogenesis</source>
          <volume>18</volume>
          <year>1997</year>
          <fpage>451</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">9054642</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>C.S.</given-names>
            </name>
          </person-group>
          <article-title>Comparison of (−)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (−/−) mice</article-title>
          <source>Pharm. Res.</source>
          <volume>22</volume>
          <year>2005</year>
          <fpage>1805</fpage>
          <lpage>1820</lpage>
          <pub-id pub-id-type="pmid">16132347</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Na</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Hyun</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Surh</surname>
              <given-names>Y.J.</given-names>
            </name>
          </person-group>
          <article-title>(−)-Epigallocatechin gallate induces Nrf2-mediated-anti-oxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells</article-title>
          <source>Arch. Biochem. Biophys.</source>
          <year>2008</year>
          <comment>(April 6 Epub)</comment>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balentine</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Wiseman</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Bouwens</surname>
              <given-names>L.C.</given-names>
            </name>
          </person-group>
          <article-title>The chemistry of tea flavonoids</article-title>
          <source>Crit. Rev. Food Sci. Nutr.</source>
          <volume>37</volume>
          <year>1997</year>
          <fpage>693</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="pmid">9447270</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tachibana</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Koga</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fujimara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>A receptor for green tea polyphenol EGCG</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>11</volume>
          <year>2004</year>
          <fpage>380</fpage>
          <lpage>381</lpage>
          <pub-id pub-id-type="pmid">15024383</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goodin</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Fertuck</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Zacharewski</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Rosengren</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro</article-title>
          <source>Toxicol. Sci.</source>
          <volume>69</volume>
          <year>2002</year>
          <fpage>354</fpage>
          <lpage>361</lpage>
          <pub-id pub-id-type="pmid">12377984</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kennedy</surname>
              <given-names>D.O.</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hasuma</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Otani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yuasa</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Growth inhibitory effect of green tea extract in Ehrlich ascites tumor cells involves cytochrome <italic>c</italic> release and caspase activation</article-title>
          <source>Cancer Lett.</source>
          <volume>166</volume>
          <year>2001</year>
          <fpage>9</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">11295281</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muto</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kamataki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450</article-title>
          <source>Mutat. Res.</source>
          <volume>479</volume>
          <year>2001</year>
          <fpage>197</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">11470492</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ikigai</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nakae</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shimamura</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Bactericidal catechins damage the lipid bilayer</article-title>
          <source>Biochem. Biophys. Acta</source>
          <volume>1147</volume>
          <year>1993</year>
          <fpage>32</fpage>
          <lpage>136</lpage>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakayama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kajiya</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kumazawa</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Affinity of polyphenols for lipid bilayers</article-title>
          <source>Biofactors</source>
          <volume>13</volume>
          <year>2000</year>
          <fpage>147</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="pmid">11237174</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamuta</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kojhima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kotoh</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Enjoji</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells</article-title>
          <source>Int. J. Mol. Med.</source>
          <volume>16</volume>
          <year>2005</year>
          <fpage>677</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="pmid">16142404</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Amelsvoort</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Van Hof</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Mathot</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Mulder</surname>
              <given-names>T.P.</given-names>
            </name>
            <name>
              <surname>Wiersma</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tijburg</surname>
              <given-names>L.B.</given-names>
            </name>
          </person-group>
          <article-title>Plasma concentrations of individual tea catechins after a single oral dose in humans</article-title>
          <source>Xenobiotica</source>
          <volume>31</volume>
          <year>2001</year>
          <fpage>891</fpage>
          <lpage>901</lpage>
          <pub-id pub-id-type="pmid">11780763</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuchiya</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yamabe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yamaquchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Konno</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tada</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Establishment and characterisation of a human acute monocytic leukaemia cell line (THP-1)</article-title>
          <source>Int. J. Cancer</source>
          <volume>26</volume>
          <year>1980</year>
          <fpage>171</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="pmid">6970727</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hosoya</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maruyama</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Kawatani</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Differential responses of the Nrf2-Keap1 system to laminar flow and oscillatory shear stress in endothelial cells</article-title>
          <source>J. Biol. Chem.</source>
          <volume>280</volume>
          <year>2005</year>
          <fpage>27244</fpage>
          <lpage>27250</lpage>
          <pub-id pub-id-type="pmid">15917255</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parker</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Murray-Rust</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>PKC at a glance</article-title>
          <source>J. Cell Sci.</source>
          <volume>117</volume>
          <year>2004</year>
          <fpage>131</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">14676268</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bloom</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Jaiswal</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylation of Nrf2 S40 by PKC in response to anti-oxidants leads to the release of Nrf2 from iNrf2 but is not required for Nrf2 stabilisation/accumulation in the nucleus and transcriptional activation of ARE-mediated NQO1 gene expression</article-title>
          <source>J. Biol. Chem.</source>
          <volume>278</volume>
          <year>2003</year>
          <fpage>44675</fpage>
          <lpage>44682</lpage>
          <pub-id pub-id-type="pmid">12947090</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levites</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Amit</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Youdim</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Mandel</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (−)-epigallocatechin-3-gallate neuroprotective action</article-title>
          <source>J. Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>30574</fpage>
          <lpage>30580</lpage>
          <pub-id pub-id-type="pmid">12058035</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levites</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Amit</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Mandel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Youdim</surname>
              <given-names>M.B.</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (−)-epigallocatechin-3-gallate</article-title>
          <source>FASEB J.</source>
          <volume>17</volume>
          <year>2003</year>
          <fpage>52</fpage>
          <lpage>954</lpage>
        </element-citation>
      </ref>
      <ref id="bib34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Ahn</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Kwak</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Phospholipase C, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and redox state are involved in epigallocatechin gallate-induced phospholipase D activation in human astroglioma cells</article-title>
          <source>Eur. J. Biochem.</source>
          <volume>271</volume>
          <year>2004</year>
          <fpage>3470</fpage>
          <lpage>3480</lpage>
          <pub-id pub-id-type="pmid">15317582</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>B.C.</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>W.K.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>K.B.</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Y.M.</given-names>
            </name>
          </person-group>
          <article-title>The anti-inflammatory activity of <italic>Phellinus linteus</italic> (Berk. &amp; M.A. Curt.) is mediated through the PKCδ/Nrf2/ARE signaling to up-regulation of heme oxygenase-1</article-title>
          <source>J. Ethnopharmacol.</source>
          <volume>113</volume>
          <year>2007</year>
          <fpage>240</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">17644290</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dickinson</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Levonen</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Moellering</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Darley-Usmar</surname>
              <given-names>V.M.</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Human glutamate cysteine ligase gene regulation through the electrophile response element</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>37</volume>
          <year>2004</year>
          <fpage>1152</fpage>
          <lpage>1159</lpage>
          <pub-id pub-id-type="pmid">15451055</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Macias</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Perrella</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice</article-title>
          <source>J. Clin. Invest.</source>
          <volume>118</volume>
          <year>2008</year>
          <fpage>239</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">18060048</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yet</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Layne</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Ith</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Sibinga</surname>
              <given-names>N.E.</given-names>
            </name>
            <name>
              <surname>Perrella</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Absence of heme oxygase-1 exacerbates atherosclerotic lesion formation and vascular remodeling</article-title>
          <source>FASEB J.</source>
          <volume>17</volume>
          <year>2003</year>
          <fpage>1759</fpage>
          <lpage>1761</lpage>
          <pub-id pub-id-type="pmid">12958201</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgment</title>
      <p>The MRC is acknowledged for funding this study.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>EGC increases HO-1 expression. (A) THP-1 cells were treated with 0–100 μM EGC for 4, 8 or 24 h. RNA was extracted, reverse transcribed and real-time PCR performed for HO-1 mRNA expression. Mean ± SD, three independent experiments. Student’s two-tailed <italic>t</italic> test, <sup>∗</sup><italic>p</italic> &lt; 0.05, <sup>∗∗</sup><italic>p</italic> &lt; 0.01. (B) THP-1 cells were treated with 100 μM EGC for indicated times, whole cell extracts prepared and Western blotting performed. Representative of three independent experiments.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Nrf2 regulates EGC-induced HO-1 mRNA expression. THP-1 cells were transfected with control or Nrf2-targeted siRNA in serum-free media for 4 h followed by addition of 10% FCS for 44 h. Following this, cells were stimulated with EGC for 4 h before RNA extraction, reverse transcription and real-time PCR analysis for Nrf2 or HO-1 mRNA expression. Mean ± SD three independent experiments. Student’s two-tailed <italic>t</italic> test, <sup>∗</sup><italic>p</italic> &lt; 0.05.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>EGC-induced HO-1 mRNA expression is PKC-dependent. THP-1 cells were pre-treated with (A) 25 μM LY294002 (LY), 25 μM PD98059 (PD), 10 μM SB203580 (SB) or 5 μM Ro-31-8220 (Ro) or (B) varying concentrations of Ro-31-8220 for 30 min prior to stimulation with 100 μM EGC for 4 h. Total RNA was extracted, reverse transcribed and HO-1 mRNA expression detected by real-time PCR. Mean ± SD three independent experiments. Student’s two-tailed <italic>t</italic> test, <sup>∗</sup><italic>p</italic> &lt; 0.05. (C) THP-1 cells were treated with 100 μM EGC for indicated times, whole cell extracts prepared and Western blotting performed. Representative of three independent experiments.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>EGC-induced HO-1 expression is PKCδ-dependent. (A) THP-1 cells were treated with 100 μM EGC for indicated times, whole cell extracts prepared and Western blotting performed. Representative of three independent experiments. (B) Cells were pre-treated with 10 μM Go6976, 0.02 μM LY333531 or 15 μM Rottlerin for 30 min prior to stimulation with 100 μM EGC for 4 h. Total RNA was extracted, reverse transcribed and HO-1 mRNA expression detected by real-time PCR. Mean ± SD three independent experiments. Student’s two-tailed <italic>t</italic> test, <sup>∗</sup><italic>p</italic> &lt; 0.05. (C) THP-1 cells were transfected with sense (SO) or antisense (ASO) ODN to PKCδ in serum-free media for 4 h followed by addition of 10% FCS for 44 h. Following transfection, cells were unstimulated or stimulated with indicated concentrations of EGC for 4 h, total RNA extracted, reverse transcribed and HO-1 mRNA expression detected by real-time PCR. Mean ± SD three independent experiments. Student’s two-tailed <italic>t</italic> test, <sup>∗</sup><italic>p</italic> &lt; 0.05.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-group>
</article>